Erlonat 150mg tablet is used in the treatment of pancreatic cancer, small cell lung cancer, liver cancer, kidney cancer, thyroid cancer, blood cancer (chronic myeloid leukaemia), gastrointestinal stromal tumour, cancer of colon and rectum, non-small cell lung cancer, soft tissue sarcoma (cancer of soft tissue), chronic idiopathic myelofibrosis and breast cancer
How it works
Erlonat 150mg tablet In patients with cancer, a change in DNA (genetic material) triggers a signal which produces abnormal cancer cells. Erlonat 150mg tablet blocks this signal, and thus stops the production of these cancer cells.
Common side effects
Nausea, Neuropathy, Nail disorder, Rash, Abdominal pain, Abnormal liver function tests, Acne, Change in body weight, Conjunctivitis, Cough, Depression, Diarrhoea, Dry skin, Shortness of breath, Fatigue, Flatulence, Flushing, Inflammation of hair follicles, Gastrointestinal bleeding, Gastrointestinal disturbance, Hair loss, Headache, Indigestion, Infection, Itching, Decreased white blood cell count, Loss of appetite, Respiratory disorder, Feeling of cold, Skin fissures, Stomatitis, Vomiting